The correlations between clinical pathologic variables and NAMPT levels in serum were reported in breast cancer patients, and the regulation regarding increased MDA-MB-231 cell invasion and migration was uncovered to be via the activation of c-Abl and STAT3 signaling [36]. The gene discussed is NAMPT; the disease is breast cancer.